Keiretsu Forum NY Tri-State Chapter

Looks like this event has already ended.

Check out upcoming events by this organizer, or organize your very own event.

View upcoming events Create an event

LIFE SCIENCES FORUM - JANUARY 18, 2011

Keiretsu Forum New York Tristate Chapter

Tuesday, January 18, 2011 from 8:00 AM to 12:00 PM (EST)

New York, United States

LIFE SCIENCES FORUM - JANUARY 18, 2011

Ticket Information

Type End     Quantity
Keiretsu Forum Life Science Forum Ended Free  
SHARE THIS EVENT

Event Details

REMINDER

 

The Keiretsu Forum Life Sciences Selection Committee is comprised of angel and venture capital investors, expert in the life sciences industry.

The Life Science Forum presentations are 25 minutes long:

  • 15-minute core presentation followed by a
  • 10-minute Question and Answer session.

After each entrepreneur presents, an Interest List is passed around the room and individual members who are interested in the company express their interest by signing in.

After all presentations are concluded, entrepreneurs are excused and Forum members discuss the companies.

PRESENTING COMPANIES:

1) Tuviderm

Built on Patented System to Remove Skin Tags

Disposable Tweezer-Like Applicator Designed Specifically for Skin Tags

2) PreEmptive Meds, Inc

A  Branded “Pharma-Nutraceutical” Company

2010 Revenue = $800,000

3) Cornerstone Pharma

Discovering and Developing Drugs to Target and Exploit the Altered Metabolism of Cancer.  3 ongoing PhaseI-I/II trials usingCPI-613

4) Immune Pharmaceuticals

Discovery, Development and Commercialization of Monoclonal Antibodies (mAbs)

-        Bertilimumab, a Phase 2 anti-eotaxin 1 mAb, originally developed by CAT (now MedImmune), for the treatment of Inflammatory Bowel Disease - Crohn’s Disease and Ulcerative Colitis- and Severe Asthma.

-           A Phase 1 anti-Fas mAb, to be co- developed with the Karolinska Institute, for the treatment of Graft vs. Host Disease following Bone Marrow Transplantation and of Toxic Epidermal Necrosis, a lethal orphan disease.

5) Business Performance Labs

Business Performance Labs provides predictive modeling and analytic software services to the very high value business process of pharmaceutical clinical studies

2010 revenue $1M

6)Prevention Pharmaceuticals

Prevention Pharmaceuticals will address the Central Nervous System (CNS) and Cardiovascular (CV) needs of the > 150 million Americans who take dietary supplements annually.  2010 revenue $450K

To refer a company to present at this meeting or any of our upcoming meetings please use our online application at http://angelsoft.net/angel-group/k4-newyork.

When & Where


425 PARK AVENUE
22nd Floor
New York, 10022

Tuesday, January 18, 2011 from 8:00 AM to 12:00 PM (EST)


  Add to my calendar

Organizer

Keiretsu Forum
New York Tristate Chapter

Keiretsu

Keiretsu Forum is the world’s largest angel investor network with 850 accredited investor members throughout eighteen chapters on three continents. Since Keiretsu Forum’s founding in 2000, its members have invested over $190m in 200+  companies in technology, consumer products, healthcare/life sciences, real estate and other segments with high growth potential. Forum members collaborate in the due diligence, but make individual investment decisions, with rounds in the range of $250k-$10m.

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.